Abera Bioscience's CEO is Maria Alriksson, appointed in Oct 2020, has a tenure of 5.75 years. directly owns 1.26% of the company’s shares, worth €194.46K. The average tenure of the management team and the board of directors is 5.1 years and 5.5 years respectively.
Key information
Maria Alriksson
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
5.8yrs
CEO ownership
1.3%
Management average tenure
5.1yrs
Board average tenure
5.5yrs
Recent management updates
Recent updates
CEO
Maria Alriksson (43 yo)
5.8yrs
Tenure
Ms. Maria Alriksson serves as Chief Executive Officer of Abera Bioscience AB since October 1, 2020. She has been Chief Marketing Officer of op5 AB since March 3, 2016. Ms. Alriksson served as the Chief Exe...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Anders Ericsson
Executive Chairman of Board
11.5yrs
no data
3.04% € 468.1k
Maria Alriksson
Chief Executive Officer
5.8yrs
no data
1.26% € 194.5k
Joen Luirink
Co-Founder & CTO
4.5yrs
no data
no data
Mats Lundgren
VP of Research & Development and CSO
4.5yrs
no data
0.12% € 18.2k
5.1yrs
Average Tenure
59.5yo
Average Age
Experienced Management: 8WK's management team is seasoned and experienced (5.1 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Anders Ericsson
Executive Chairman of Board
11.5yrs
no data
3.04% € 468.1k
Christina Glad
Director
5.6yrs
no data
0.029% € 4.5k
Jan-Willem De Gier
Member of Advisory Board
no data
no data
no data
Samuel Wagner
Member of Advisory Board
no data
no data
no data
Camille Locht
Member of the Advisory Board
5.5yrs
no data
no data
Fredrik Juserius
Director
5.6yrs
no data
0.071% € 10.9k
Marien de Jonge
Member of the Advisory board
4.5yrs
no data
no data
Lucille Beek
Member of the Advisory Board
3.5yrs
no data
no data
Harry Rastedt
Director
2.5yrs
no data
0.32% € 48.8k
5.5yrs
Average Tenure
58.5yo
Average Age
Experienced Board: 8WK's board of directors are considered experienced (5.5 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/08 12:13
End of Day Share Price
2026/07/08 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Abera Bioscience AB is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.